Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elena I. Gavrila
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Cancer Discovery
Oncology
Related publications
Author Correction: HER Kinase Inhibition in Patients With HER2- And HER3-mutant Cancers
Nature
Multidisciplinary
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
HER2-Orientated Therapy in Early and Metastatic Breast Cancer
Breast Care
Surgery
Oncology
HER2 Expression in NF1 Breast Cancer—Response
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer
ESMO Open
Cancer Research
Oncology
Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Inhibition of Ezrin Causes PKCα-mediated Internalization of Erbb2/Her2 Tyrosine Kinase in Breast Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Assessing the Tolerability and Efficacy of First-Line Chemotherapy in Elderly Patients With Metastatic HER2−ve Breast Cancer
ecancermedicalscience
Cancer Research
Oncology
PTEN Expression as a Predictor for the Response to Trastuzumab-Based Therapy in Her-2 Overexpressing Metastatic Breast Cancer
PLoS ONE
Multidisciplinary